01What "Marketing Redefined" Actually Means — A Strict Definition First

"Marketing is being redefined" is a phrase used loosely. Let's give it a strict definition. This is not a story about "newer tools" or "more automation." Those are surface changes. In this series, "redefinition" refers to a deeper shift — both the purpose that marketing tries to achieve, and the systems of means required to achieve that purpose, are changing at the same time.

Two specific shifts are happening together:

These two shifts are not independent. They are deeply entangled, and trying to isolate one without the other produces an incomplete picture. That is precisely why we call this a redefinition — the whole shape has to be redrawn.

02The Four-Element Map — Advertising / CRM / Content / Brand

Let's decompose marketing into its working parts. Classical frameworks abound — 4P (Product / Price / Place / Promotion), STP (Segmentation / Targeting / Positioning) — but for this series, we organize around the four elements that practitioners actually live with day to day.

Element 01

Advertising

handles "reaching"

Acquire awareness from new audiences and announce the product's existence. Mass advertising, digital ads, retargeting — and in pharma, DTC advertising or information delivery through MR to healthcare professionals.

Element 02

CRM (Customer Relationship Management)

handles "remembering"

Sustain the relationship with existing customers. Accumulate purchase history, preferences, and contact history; deliver the right information at the right time. In pharma — physician-by-physician prescribing patterns, contact logs, and specialty management.

Element 03

Content

handles "creating"

The information, story, and experience itself, delivered to the customer. Articles, videos, social posts, brochures, MR briefing decks — all content. The element undergoing the most violent change from generative AI.

Element 04

Brand

handles "earning trust"

The customer's accumulated, gestalt impression of the company or product, built across all four elements. Slow to build, instantaneous to lose. In pharma — most heavily, the structure of "trust as a good."

None of the four elements operates in isolation. Awareness from advertising becomes a relationship through CRM; understanding from CRM informs the content; the accumulation of content composes the brand. They form a coupled system. So when AI enters any one element, its effects propagate through the adjacent ones. That coupling is the central premise of this series.

03Advertising — "Reaching" Gets Rewritten

Advertising was the first element to be colonized by AI. Google's and Meta's ad platforms already automate bidding, delivery, and creative generation. The space for a human operator to manually tune anything has shrunk fast.

But the bid-optimization story misses the real shift. Three things matter more:

For pharma, this maps directly onto the changing role of the MR. When physicians ask Claude or GPT for specs and clinical data, can MR still survive as "the person who carries information"? That is the question for this series, Vol. 6.

04CRM — "Remembering" Gets Rewritten

CRM has traditionally been a combination of database + rules + the rep's memory. In Salesforce or Veeva, you write down past contacts and the next action; the rep reads it and decides what to do.

With AI in the loop, that structure shifts:

Legacy CRMCRM in the AI Era
Historical data is "stored"History is used to predict the customer's emotion / interest / next information need
The rep decides the next actionAn AI agent proposes candidate actions; the rep becomes the decision-maker
Programs are designed at segment level1:1 personalization becomes economically viable
"Tacit understanding" stays in the rep's headCustomer understanding is captured as organizational knowledge in the AI, making handoff easy

In pharma MR, the way Veeva CRM and proprietary CRM tools are used is shifting fast. After a conversation with a physician, "How did this physician react? What might they want to ask next?" — an AI predicts the answer and proposes the next-visit scenario. This is no longer in pilot. Several global MR organizations now run it in production.

05Content — "Creating" Gets Rewritten

Content is where generative AI moves the fastest. Articles, images, videos, decks, social posts — what dedicated creators used to spend days on can now be produced in minutes or hours.

A common misreading is "so human creators become unnecessary." The reality is the inverse. The mass supply of AI-generated content without human creative intent has, paradoxically, raised the scarcity value of creators with a real voice and perspective. As AI content becomes the baseline, makers with a real point of view become rarer and more valuable.

The other major shift is fit-for-audience optimization. With generative AI, you can realistically take a single source and ship one version for physicians, another for patients, another for pharmacists, another for sales-office managers. "One brochure for everyone" gives way to "a tailored version per audience." In pharma MR field operations, this is already standard.

The pharma-specific complication: Pharmaceutical content is governed by the Pharmaceutical Act §§66–68, by material review, and by Japan's Sales Information Provision Activity Guideline. The fact that AI can generate at volume does not mean it can ship without review. If "creation speed" outpaces "review capacity," the risk of exaggerated claims and off-label promotion rises sharply. This is the theme of Vol. 5 in this series.

06Brand — "Earning Trust" Gets Rewritten

Of the four elements, brand is the slowest to be touched by AI — and arguably the one that will change most deeply. Brand is the customer's gestalt impression of the company or product, built up over time across advertising, CRM, and content. It is not something AI can generate directly.

So what changes? A new concept — Vibe Marketing — is reshaping how brand design is even discussed. The idea: deliberately design the "vibe" — the tone, the atmosphere, the feel — and let generative AI propagate it consistently across the massive volume of content the brand now produces. Color, tone of voice, word choice, whitespace, tempo — every output, generated at scale, infused with the same "shape" that defines this brand.

In the pharmaceutical context, this points beyond the classic two-layer structure of corporate brand plus product brand. It points toward "the 1:1 relationship with each physician itself becoming the brand." The voice, tempo, and integrity of each individual MR becomes the brand's final line of defense in an era where AI does the information-carrying. That is the deep theme we'll tackle in Vols. 9 and 10.

07The Coupling — Not One Element, But the Whole System

The four elements have been described separately, but in practice they move together. Awareness from advertising becomes the entry point to CRM; conversations within CRM become the raw material for content; the accumulation of content shapes the brand. AI strengthens and transforms this chain simultaneously.

For the practitioner, this coupling is a double-edged sword:

This is why every chapter in the series ends with an explicit consideration of "how this connects to the other three elements." The era of optimizing advertising in isolation, or CRM in isolation, is over.

08The Ten-Part Map

Here is the planned structure of the series, organized against the four-element map. Use it as a compass while reading.

  1. Vol. 01
    Marketing Redefined for the AI Era (this piece)
    The four-element map and the navigation chart for the entire series
  2. Vol. 02
    Vibe Marketing — Designing a Brand's "Atmosphere" With AI
    Entry point for the brand element; coherent design across generative-AI content at scale
  3. Vol. 03
    Generative-AI Content — Volume and "Voice" Simultaneously
    Center of the content element; how human creators and AI divide labor
  4. Vol. 04
    Advertising × AI — Past Bid Optimization, Toward Being "Chosen" by AI Agents
    The essence of the advertising element; LLMO (Large Language Model Optimization)
  5. Vol. 05
    Regulated Pharma Content × AI — Balancing Speed and Review
    The intersection of content with the Pharmaceutical Act and HanteiG; material review in the AI era
  6. Vol. 06
    MR × AI — From Carrying Information to Designing Relationships
    Convergence of advertising and CRM; rebuilding the physician relationship
  7. Vol. 07
    DTC Advertising × AI — Direct Communication With Patients
    The OTC / consumer application of the advertising element; the space between regulation and freedom
  8. Vol. 08
    CRM × AI — Reading the Customer's State of Mind
    Deepening the CRM element; the ethical boundary of emotion prediction
  9. Vol. 09
    Brand Design in the Era of AI Agents
    The final shape of the brand element; a world where AI agents act as customer proxies
  10. Vol. 10
    Integration — Tying the Four Elements Into One Strategy
    Series conclusion; organizational design and decision-making

09What This Means for Pharmaceutical Marketing — Regulation and Brand, Held Together

This series is written primarily for pharmaceutical marketing practitioners. Unlike a general marketing series, in pharma regulation always sits in the next chair over. Advertising is bound by the Pharmaceutical Act; content has to pass material review; CRM lives at the intersection of personal data protection law and relational ethics; and brand depends on the architecture of social trust.

Adopting AI does not loosen any of these constraints. The day-to-day task is the opposite: designing how AI and regulation coexist in the field. This series walks through that coexistence concretely, chapter by chapter.

Of those three, this series aims at the third. We treat AI not as a tool for skirting regulation or winning a speed race, but as infrastructure that supports the "trust as a good" essence of pharmaceutical products at a higher level. That is the question pharmaceutical marketing must answer in the AI era.

10Connections to Other Chapters on This Site

The AI Marketing series connects to other parts of the site as follows. Reading them together gives the depth this material deserves.

In Closing

For most of its history, marketing has been "people, communicating to people." Reach with advertising, remember with CRM, tell a story with content, earn trust with brand — these four moved by human hands and human judgment.

What is happening from 2024 to 2026 is that all four elements are being rewritten by AI at the same time. Advertising shifts toward delivery into AI agents, CRM shifts toward emotion prediction, content shifts toward mass generation, brand shifts toward Vibe design — and not as independent transitions, but as a coupled change.

The purpose of this series is to take that redefinition head-on in the pharmaceutical context. Speeding things up with AI is not enough. Use AI to the hilt while holding regulation and trust together — that is the map we will draw over the next ten installments. Next time, we go deep into the brand element: Vibe Marketing.